On Target Laboratories Taps Philips Healthcare’s Barys for CEO

Christopher Barys has been appointed CEO of On Target Laboratories. Barys is also joining the West Lafayette, IN-based company’s board of directors. He succeeds former CEO Martin Low. Barys comes to On Target from Philips Healthcare, where he led the company’s image guided therapy group. Barys’s experience also includes positions at Medtronic (NYSE: [[ticker:MDT]]) and Kimberly-Clark (NYSE: [[ticker:KMB]]). On Target, which is developing an imaging technology meant to help surgeons more easily see cancer cells, has advanced to Phase 3 testing in ovarian cancer and Phase 2 testing in lung cancer.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan